Home/Filings/4/0001209191-23-007318
4//SEC Filing

Cahill Brian Joseph 4

Accession 0001209191-23-007318

CIK 0000827871other

Filed

Feb 5, 7:00 PM ET

Accepted

Feb 6, 4:48 PM ET

Size

4.9 KB

Accession

0001209191-23-007318

Insider Transaction Report

Form 4
Period: 2023-02-02
Cahill Brian Joseph
Chief Financial Officer
Transactions
  • Tax Payment

    Common Stock

    2023-02-02$34.09/sh785$26,76130,086 total
Footnotes (1)
  • [F1]The disposition reported on this Form 4 represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units.

Issuer

EAGLE PHARMACEUTICALS, INC.

CIK 0000827871

Entity typeother

Related Parties

1
  • filerCIK 0001831591

Filing Metadata

Form type
4
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 4:48 PM ET
Size
4.9 KB